Free Trial

STERIS plc (NYSE:STE) Holdings Lowered by Mariner LLC

STERIS logo with Medical background

Mariner LLC lowered its holdings in STERIS plc (NYSE:STE - Free Report) by 10.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,536 shares of the medical equipment provider's stock after selling 1,271 shares during the period. Mariner LLC's holdings in STERIS were worth $2,166,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of STE. Norges Bank purchased a new stake in STERIS during the 4th quarter worth about $238,836,000. Raymond James Financial Inc. acquired a new stake in shares of STERIS during the fourth quarter worth about $223,987,000. Franklin Resources Inc. grew its stake in shares of STERIS by 171.2% in the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after purchasing an additional 529,308 shares during the last quarter. Wellington Management Group LLP increased its stake in STERIS by 4,534.6% in the 4th quarter. Wellington Management Group LLP now owns 219,032 shares of the medical equipment provider's stock valued at $45,024,000 after buying an additional 214,306 shares during the period. Finally, Boston Trust Walden Corp raised its holdings in STERIS by 400.4% during the fourth quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider's stock worth $46,198,000 after purchasing an additional 179,829 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.

STERIS Stock Performance

Shares of NYSE STE traded down $0.70 during trading on Tuesday, reaching $224.56. The stock had a trading volume of 97,457 shares, compared to its average volume of 524,723. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The stock has a market cap of $22.06 billion, a PE ratio of 47.66 and a beta of 0.87. STERIS plc has a one year low of $200.98 and a one year high of $248.24. The firm's 50 day moving average price is $222.97 and its two-hundred day moving average price is $218.84.

STERIS (NYSE:STE - Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, research analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. JMP Securities reaffirmed a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, April 10th. Stephens reiterated an "overweight" rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler increased their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

View Our Latest Stock Report on STE

STERIS Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Stories

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Should You Invest $1,000 in STERIS Right Now?

Before you consider STERIS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.

While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines